Optinose

Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials

YARDLEY, PA — Optinose (NASDAQ: OPTN), a Pennsylvania-based pharmaceutical company, has announced the publication of results from its ReOpen1 and ReOpen2 clinical trials. The findings, published in the reputable Journal …

Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials Read More
Nexgel

NEXGEL CEO to Present at Prestigious Microcap Conference, Highlighting its Strategic Role in the Healthcare Sector

LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: “NXGL”), a Pennsylvania-based company known for its innovative solutions in the healthcare sector, has announced that its Chief Executive Officer, Adam Levy, will be …

NEXGEL CEO to Present at Prestigious Microcap Conference, Highlighting its Strategic Role in the Healthcare Sector Read More

Election News

DLCC Eyes Critical Pennsylvania Race Following Florida Victory, With Political Power Hanging in the Balance

WASHINGTON, D.C. — Fresh off a significant win in Florida, the Democratic Legislative Campaign Committee (DLCC) is setting its sights on a high-stakes special election in Pennsylvania’s battleground Bucks County. …

DLCC Eyes Critical Pennsylvania Race Following Florida Victory, With Political Power Hanging in the Balance Read More
Windtree Therapeutics

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant license agreement with Lee’s Pharmaceutical (HK) Limited (“Lee’s”), a leading Hong Kong-based pharmaceutical company. The deal involves the …

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments Read More